New Sight-Saving Ophthalmic Drug a Culmination of Decade-Long Collaboration Between Singapore Eye Research Institute and Roche
Vabysmo® (faricimab) is the first dual-action drug targeting neovascular age-related macular degeneration and diabetic macular oedema, potentially reducing the treatment burden in patients. The...